358 related articles for article (PubMed ID: 28763099)
1. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.
Obreque J; Vega F; Torres A; Cuitino L; Mackern-Oberti JP; Viviani P; Kalergis A; Llanos C
Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice.
Funes SC; Ríos M; Gómez-Santander F; Fernández-Fierro A; Altamirano-Lagos MJ; Rivera-Perez D; Pulgar-Sepúlveda R; Jara EL; Rebolledo-Zelada D; Villarroel A; Roa JC; Mackern-Oberti JP; Kalergis AM
Immunology; 2019 Dec; 158(4):322-339. PubMed ID: 31509246
[TBL] [Abstract][Full Text] [Related]
3. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
Wu H; Lo Y; Chan A; Law KS; Mok MY
Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
Harry RA; Anderson AE; Isaacs JD; Hilkens CM
Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus.
Decker P; Kötter I; Klein R; Berner B; Rammensee HG
Rheumatology (Oxford); 2006 Sep; 45(9):1087-95. PubMed ID: 16527880
[TBL] [Abstract][Full Text] [Related]
6. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.
Ding D; Mehta H; McCune WJ; Kaplan MJ
J Immunol; 2006 Nov; 177(9):5878-89. PubMed ID: 17056512
[TBL] [Abstract][Full Text] [Related]
7. Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics.
Esmaeili SA; Mahmoudi M; Rezaieyazdi Z; Sahebari M; Tabasi N; Sahebkar A; Rastin M
J Cell Biochem; 2018 Sep; 119(9):7865-7872. PubMed ID: 29943843
[TBL] [Abstract][Full Text] [Related]
8. A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.
García-González P; Morales R; Hoyos L; Maggi J; Campos J; Pesce B; Gárate D; Larrondo M; González R; Soto L; Ramos V; Tobar P; Molina MC; Pino-Lagos K; Catalán D; Aguillón JC
J Transl Med; 2013 May; 11():128. PubMed ID: 23706017
[TBL] [Abstract][Full Text] [Related]
9. GENERATION OF TOLEROGENIC DENDRITIC CELLS UNDER THE PERSISTENT INFLAMMATION STIMULATION.
Miao S; Chang Z; Gu B; Jiang J; Pei F; Liu Y; Zhou Y; Liu Z; Si X; Guan X; Wu J
Shock; 2024 Mar; 61(3):454-464. PubMed ID: 38412105
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells generated in the presence of vitamin D3 and stimulated with lipopolysaccharide secrete IL-8, IL-1β, IL-10 and induce relatively low levels of CD4+CD25hiFoxp3+ T cells.
Muñoz SM; Rodríguez LS
Biomedica; 2016 Jun; 36(2):239-50. PubMed ID: 27622485
[TBL] [Abstract][Full Text] [Related]
11. Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.
Dixon KO; van der Kooij SW; Vignali DA; van Kooten C
Eur J Immunol; 2015 Jun; 45(6):1736-47. PubMed ID: 25820702
[TBL] [Abstract][Full Text] [Related]
12. Phenotype and function of dendritic cells of patients with systemic lupus erythematosus.
Crispín JC; Vargas-Rojas MI; Monsiváis-Urenda A; Alcocer-Varela J
Clin Immunol; 2012 Apr; 143(1):45-50. PubMed ID: 22239954
[TBL] [Abstract][Full Text] [Related]
13. Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function.
Wu HJ; Lo Y; Luk D; Lau CS; Lu L; Mok MY
Clin Immunol; 2015 Jan; 156(1):43-57. PubMed ID: 25463431
[TBL] [Abstract][Full Text] [Related]
14. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
Mok MY
Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
[TBL] [Abstract][Full Text] [Related]
16. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus.
Monsiváis-Urenda AE; Baranda L; Alvarez-Quiroga C; Abud-Mendoza C; González-Amaro R
J Clin Immunol; 2011 Jun; 31(3):369-78. PubMed ID: 21188486
[TBL] [Abstract][Full Text] [Related]
18. Allergoid-mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring.
Benito-Villalvilla C; Pérez-Diego M; Angelina A; Kisand K; Rebane A; Subiza JL; Palomares O
J Allergy Clin Immunol; 2022 Jan; 149(1):212-222.e9. PubMed ID: 34153371
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin treated tol-dendritic cells derived from BM-MSCs reversed graft rejection in a rat liver transplantation model by inducing CD8
Zhou L; Li H; Zhang XX; Zhao Y; Wang J; Pan LC; Du GS; He Q; Li XL
Mol Immunol; 2021 Sep; 137():11-19. PubMed ID: 34182227
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus.
Mikołajczyk TP; Skiba D; Batko B; Krezelok M; Wilk G; Osmenda G; Pryjma JR; Guzik TJ
Lupus; 2014 Nov; 23(13):1358-69. PubMed ID: 24969081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
